Newsroom
Category
March 28, 2022
Contact: Eileen Teves, 210-450-7239, tevese@uthscsa.edu SAN ANTONIO, March 28, 2022 – UT Health San Antonio’s Greehey Children’s Cancer Research Institute (GCCRI) is hosting its inaugural cycling event, Gear Up Against Kids Cancer, on Saturday, April 2. Cyclists will gather at the Floresville Event Center where the bike ride will begin and end. Riders will take either […]
March 28, 2022
Structural racism, rather than disease, leads to inequities, authors write Contacts: Will Sansom, (210) 567-2579, sansom@uthscsa.edu Steven Lee, (210) 450-3823, lees22@uthscsa.edu SAN ANTONIO (March 28, 2022) — Black patients with cancer experienced significantly worse outcomes after COVID-19 diagnosis than non-Hispanic white cancer patients in a study published March 28 in JAMA Network Open. Investigators of […]
March 21, 2022
Will provide more career opportunities for students Contact: Eileen Teves, 210-450-7239, tevese@uthscsa.edu LAREDO, Texas, March 21, 2022 – UT Health San Antonio’s School of Health Professions invites Webb County students interested in a health career to learn more about its nationally recognized Master of Physician Assistant Studies program. Expanded to Laredo in the summer of […]
March 18, 2022
Contact: Will Sansom, (210) 567-2579, sansom@uthscsa.edu SAN ANTONIO (March 18, 2022) — Ruben A. Mesa, MD, FACP, professor of medicine and executive director of the Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, testified on clinical trial diversity yesterday (March 17, 2022) before the House Committee on Energy and Commerce. The […]
March 11, 2022
Contact: Will Sansom, (210) 567-2579, sansom@uthscsa.edu SAN ANTONIO (March 11, 2021) — Cancer and virology researcher Reuben Harris, PhD, has been named chairman of the Department of Biochemistry and Structural Biology at The University of Texas Health Science Center at San Antonio (UT Health San Antonio). The department is in the Joe R. and Teresa Lozano […]
March 10, 2022
Contact: Steven Lee, 210-450-3823, lees22@uthscsa.edu SAN ANTONIO – An internationally recognized physician-scientist of Mays Cancer Center at UT Health San Antonio together with SignalRx Pharmaceuticals Inc. have secured two National Cancer Institute business grants to further develop drugs on a pathway to first-in-human cancer clinical trials. The clinical translational researcher, Daruka Mahadevan, MD, PhD, division […]
